Crossmark

Recall of ibrutinib and issues with therapeutic approval

Crossref DOI link: https://doi.org/10.1136/bmjonc-2024-000418

Published Online: 2024-08-07

Published Print: 2024-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Lipfert, Colton

Kim, Myung Sun https://orcid.org/0000-0002-2042-1262
Haslam, Alyson https://orcid.org/0000-0002-7876-3978
Prasad, Vinay K
Funding

Funding for this research was provided by:

Arnold Ventures (NA)
License Information

License valid from 2024-08-07